Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine

Naoko Hosono, Naoko Ida, Takahiro Yamauchi

Open source

DOI
10.1016/j.bcp.2026.118440
Published
2026-12
Container
Biochemical Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bcp.2026.118440,
  title = {Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine},
  author = {Naoko Hosono and Naoko Ida and Takahiro Yamauchi},
  year = {2026},
  journal = {Biochemical Pharmacology},
  doi = {10.1016/j.bcp.2026.118440},
  url = {https://doi.org/10.1016/j.bcp.2026.118440}
}

RIS

TY  - JOUR
TI  - Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine
AU  - Naoko Hosono
AU  - Naoko Ida
AU  - Takahiro Yamauchi
PY  - 2026
JO  - Biochemical Pharmacology
DO  - 10.1016/j.bcp.2026.118440
UR  - https://doi.org/10.1016/j.bcp.2026.118440
ER  - 

APA

Hosono, N., Ida, N., & Yamauchi, T. (2026). Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118440

Source records